British stocks tumbled as pharmaceutical shares slumped due to escalating tariffs between the U.S. and China. The FTSE 100 ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

In the US, President Donald Trump’s tariff threats on pharmaceutical imports have rattled major drugmakers, sending shockwaves through FTSE 100 stocks. Meanwhile, across the Atlantic, a £100 million ...

Ohio and Indiana are suing the makers of a popular heartburn medication, saying the drug company concealed cancer risks and cost investors billions.

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________ SCHEDULE 14 A Proxy Statement Pursuant to Section 14 of the Securities Exchange Act of ...

The pharmaceutical company says it will continue to operate its production facility near Research Triangle Park.

In its first full year on the U.S. market, bladder cancer treatment Adstiladrin earned about $77 million. Elsewhere, Lilly ...